NCT07392060 2026-02-06A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based TreatmentShanghai Jiatan Pharmatech Co., LtdPhase 3 Not yet recruiting440 enrolled